Not yet medically reviewed, information on this site is in preparation and has not been verified by a medical reviewer.
Legality · MDPV

Is MDPV legal in United Arab Emirates?

Also known as: monkey dust

Confirmed against a primary sourceVerified September 21, 2026
Legal status
This compound is named in the cathinones block of Schedule 5 of Decision No. 158 of 2025, at item 3, subitem 25. The entry is «MDPV؛ 3،4-ميثيلين ديوكسي بيروفاليرون», and the dossier renders the chemical name as 3,4-Methylenedioxypyrovalerone. The enumeration is the point: the same schedule carries the parent alkaloid cathinone at its own entry, and the substituted members are listed individually in the item 3 block, so this row is controlled because subitem 25 names it and not because it is a cathinone derivative. The dossier's search on a neighbouring row records that the block prints some named analogues and not others, which is what an enumerated block looks like in practice. The row runs through Articles 10, 41 and 57, with Schedule 10 group 1 carrying the quantity band. The placement was read on 20 September 2026.
Consequences if caught
Item 3, subitem 25 of Schedule 5 puts this row in one of the four schedule groups Article 57 names. The dossier records the article as stating mandatory death for its trafficking or promotion trigger and as stating no quantity, so the capital exposure follows from the subitem placement and the conduct. Schedule 10 assigns a group 1 band to the substance, and the dossier records that the bands do not gate the Article 57 route, so the band is not the threshold it looks like. On a substituted cathinone this matters twice over, because the question that decides the row is which member was proved rather than how much of it there was. Article 41 carries the personal use route for this branch, with no tariff stated.
If prescribed or medical
The dossier records at the modafinil row that a 268 entry ministry travellers list was checked and expressly not used as a schedule. Attached to this substance: the placement at Schedule 5, item 3, subitem 25, with no medicinal product or prescribing route recorded against it. No permit procedure is described for the Schedule 5 branch, so the medical question is deferred rather than answered.
Documentation
No documentation route is recorded for this substance. Provenance: the entry «MDPV؛ 3،4-ميثيلين ديوكسي بيروفاليرون» at item 3, subitem 25 was read on 20 September 2026, with the capital analysis resting on Article 57 and not on the group 1 band. The practical point is that material described only as a synthetic cathinone is not placed by this row, because the block names its members and a member it does not name is a separate question.
Primary sources
  • United Arab Emirates, Decision No. 158 of 2025, Schedule 5, item 3 (cathinones), subitem 25, printed entry «MDPV؛ 3،4-ميثيلين ديوكسي بيروفاليرون», an enumerated member of the cathinones block rather than a substance reached by the parent cathinone entry
  • Articles 10, 41 and 57 attach to this branch and the Schedule 10 group 1 band does not gate Article 57, which states no quantity
  • the schedule text was read at https://sha.shj.ae/#:~:text=MDPV and the article text at https://uaelegislation.gov.ae/ar/legislations/1540#:~:text=%D8%A7%D9%84%D9%85%D8%A7%D8%AF%D8%A9%2057, the federal legislation portal
  • the instrument is written in Arabic and the English chemical rendering is the dossier's
  • read as at 20 September 2026

Court records

We have not yet assessed whether court records are publicly available for this jurisdiction.

Other substances confirmed in United Arab Emirates

Same substance, other countries